Home      Login

Abstract: 

Our regular survey of the research literature includes summaries of “Pregnant Inmates with OUD Experience Inconsistencies in Medical Treatment” By Gary Enos, published in 32 Alcoholism & Drug Abuse Weekly 1; “Effectiveness of COVID-19 Vaccines Among Incarcerated People in California State Prisons: Retrospective Cohort Study” by Elizabeth T. Chin, David Leidner, Yifan Zhang, Elizabeth Long, Lea Prince, Stephanie J. Schrag, Jennifer R. Verani, Ryan E. Wiegand, Fernando Alarid-Escudero, Jeremy D. Goldhaber-Fiebert, David M. Studdert, Jason R. Andrews, and Joshua A. Salomon, published in 10 Clinical Infectious Diseases (2022) (published online ahead of print), https://doi.org/10.1093/cid/ciab1032; “Trends in Buprenorphine Use in US Jails and Prisons From 2016 to 2021” by Ashish P. Thakrar, G. Caleb Alexander, and Brendan Saloner, published in 4 JAMA Network Open e2138807 (Dec. 2021); “Buprenorphine/Naloxone Access for People with Opioid Use Disorder in Correctional Facilities: Taking Steps to Support Knowledge Translation” by Lori Regenstreif, Marina Sadik, Erin Beaulieu, Claire Bodkin, Lori Kiefer, Dale Guenter, Patsy W. P. Lee, and Fiona G. Kouyoumdjian, published in 10 Health and Justice (2022); “A Pilot TB Screening Model in a U.S. Prison Population Using Tuberculin Skin Testing (TST) and Interferon Gamma Release Assay (IGRA) Based on Country of Origin” by Roxanne P. Kerani, Adrienne E. Shapiro, and Lara B. Strick, published in 27 Journal of Correctional Health Care 259 (2021).

Keywords: Pregnant Inmates with Opioid Use Disorder; Effectiveness of COVID-19 Vaccines; Buprenorphine Use in Correctional Settings; Naloxone; TB Screening

Affiliations:  1: Pace University Law School.